Researches

Faculty of Pharmacy

Assiut University

# Title Department Research Year
841 Innovative HPTLC Method with Fluorescence Detection for Assessment of Febuxostat-Montelukast Combination and Study of Their Protective Effects Against Gouty Arthritis Department of Pharmaceutical Analytical Chemistry 2018
842 New, simple and sensitive HPTLC method for simultaneous determination of anti-hepatitis C sofosbuvir and ledipasvir in rabbit plasma Department of Pharmaceutical Analytical Chemistry 2018
843 3-Amino-5-pyridin-3-yl-1,2,4-triazole, a novel fluorescence probe for
trace analysis of silymarin in bulk material, pharmaceutical dosage forms
and human plasma: Further insights on reaction mechanism using
computational molecular modeling and NMR spec 		Department of Pharmaceutical Analytical Chemistry 2018
844 Optimization of siRNA delivery to target sites: issues and future directions Department of Pharmaceutics 2018
845 Enhanced dispersive solid phase extraction assisted
by cloud point strategy prior to fluorometric
determination of anti-hepatitis C drug velpatasvir in
pharmaceutical tablets and body fluids 		Department of Pharmaceutical Analytical Chemistry 2018
846 Efficient HPTLC-dual wavelength spectrodensitometric method for simultaneous determination of sofosbuvir and daclatasvir: Biological and pharmaceutical analysis Department of Pharmaceutical Analytical Chemistry 2018
847 Novel Targeted Lipid Nanoparticles Loaded with Synergistic Chemotherapy- Gene therapy Combination for Effective Treatment of Hepatocellular Carcinoma Department of Pharmaceutics 2018
848 A Localized Surface Plasmon Resonance Sensing Method for Simultaneous Determination of Atenolol and Amiloride in Pharmaceutical Dosage Forms and Urine Samples Department of Pharmaceutical Analytical Chemistry 2018
849 Novel N-Substituted 5-aminosalicylamides as Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase Enzymes: Synthesis, Biological Evaluation and Docking Study Department of Pharmaceutical Organic Chemistry 2018
850 Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits Department of Pharmaceutical Analytical Chemistry 2018